These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26092075)

  • 1. The Reply.
    Salazar MR; Reaven GM
    Am J Med; 2015 Jul; 128(7):e27. PubMed ID: 26092075
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of the Visceral Adiposity Index in Different Populations.
    Peng TC; Chen WL; Kao TW
    Am J Med; 2015 Jul; 128(7):e25-6. PubMed ID: 26092074
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular disease under the influence of excess visceral fat.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visceral fat and metabolic syndrome: more than a simple association].
    Ribeiro Filho FF; Mariosa LS; Ferreira SR; Zanella MT
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):230-8. PubMed ID: 16767289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to DN Polesel et al.
    Liu A; Reaven GM; Abbasi F
    Am J Clin Nutr; 2013 Dec; 98(6):1593. PubMed ID: 24259357
    [No Abstract]   [Full Text] [Related]  

  • 6. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk.
    Mathieu P; Boulanger MC; Després JP
    Rev Endocr Metab Disord; 2014 Dec; 15(4):289-98. PubMed ID: 25326657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical indications and proper use of Visceral Adiposity Index.
    Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):e31-2. PubMed ID: 23786826
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic syndrome and aldosterone].
    Nagase M; Fujita T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1726-30. PubMed ID: 17037306
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of metabolic syndrome].
    Nakamura T; Okauchi Y; Ryo M; Funahashi T; Shimomura I
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1731-6. PubMed ID: 17037307
    [No Abstract]   [Full Text] [Related]  

  • 11. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study.
    Sone H; Tanaka S; Ishibashi S; Yamasaki Y; Oikawa S; Ito H; Saito Y; Ohashi Y; Akanuma Y; Yamada N;
    Diabetes Care; 2006 Jan; 29(1):145-7. PubMed ID: 16373914
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic syndrome.
    Opie LH
    Circulation; 2007 Jan; 115(3):e32-5. PubMed ID: 17242286
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome.
    Maggio AB; Mueller P; Wacker J; Viallon M; Belli DC; Beghetti M; Farpour-Lambert NJ; McLin VA
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):720-6. PubMed ID: 22157928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does menopause make your heart sick? Not according to MONET.
    Polotsky AJ
    Menopause; 2012 Jul; 19(7):722-3. PubMed ID: 22735097
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolic syndrome and visceral fat in women with cardiovascular risk factor].
    Soto Rodríguez A; García Soidán JL; Arias Gómez MJ; Leirós Rodríguez R; Del Álamo Alonso A; Pérez Fernández MR
    Nutr Hosp; 2017 Jul; 34(4):863-868. PubMed ID: 29095010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prevalence of metabolic syndrome in middle-aged in Kaunas population].
    Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R
    Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new look at the genetic and environmental coherence of metabolic syndrome components.
    Panizzon MS; Hauger RL; Sailors M; Lyons MJ; Jacobson KC; Murray McKenzie R; Rana B; Vasilopoulos T; Vuoksimaa E; Xian H; Kremen WS; Franz CE
    Obesity (Silver Spring); 2015 Dec; 23(12):2499-507. PubMed ID: 26524476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
    Després JP; Ross R; Boka G; Alméras N; Lemieux I;
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risks in adolescents with different degrees of obesity.
    Torres KP; Torres SG; Guerra RO
    Arq Bras Cardiol; 2011 Aug; 97(2):179; author reply 180. PubMed ID: 22002030
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular consequences of metabolic syndrome.
    Tune JD; Goodwill AG; Sassoon DJ; Mather KJ
    Transl Res; 2017 May; 183():57-70. PubMed ID: 28130064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.